Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo

OBJECTIVES: Iron is an essential element for cell proliferation and growth processes. We have reported that deferasirox (DFX), an oral iron chelator, showed antiproliferative activity against pancreatic cancer cells. This study aimed to elucidate the effects of combination of gemcitabine (GEM), stan...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinoda, Shuhei, Kaino, Seiji, Amano, Shogo, Harima, Hirofumi, Matsumoto, Toshihiko, Fujisawa, Koichi, Takami, Taro, Yamamoto, Naoki, Yamasaki, Takahiro, Sakaida, Isao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033369/
https://www.ncbi.nlm.nih.gov/pubmed/29983871
http://dx.doi.org/10.18632/oncotarget.25421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033369/
https://www.ncbi.nlm.nih.gov/pubmed/29983871
http://dx.doi.org/10.18632/oncotarget.25421

Ejemplares similares